Barth M L, Fensom A, Harris A
Division of Medical and Molecular Genetics, UMDS-Guy's Campus, London, UK.
Hum Mol Genet. 1993 Dec;2(12):2117-21. doi: 10.1093/hmg/2.12.2117.
Novel predicted disease-causing mutations have been defined in three patients with metachromatic leukodystrophy (MLD). The first new mutation is a C-->A change at base 884 in exon 5 of the arylsulphatase A (ASA) gene causing a serine to tyrosine substitution at position 295 of the protein (S295Y). A late-infantile MLD patient was found to be homozygous for this mutation. The second mutation is a G-->A substitution at nucleotide 1144 in exon 7, that causes a glutamic acid to lysine substitution at amino acid 382 (E382K). A juvenile MLD patients was found to be homozygous for this mutation. Finally an adult MLD patient has been shown to be heterozygous for two novel point mutations in exon 3. These are both C-->T changes at position 635 and 671 that result in alanine to valine substitutions at amino acids 212 (A212V) and 224 (A224V) of the ASA protein.
已在三名异染性脑白质营养不良(MLD)患者中确定了新的预测致病突变。第一个新突变是芳基硫酸酯酶A(ASA)基因第5外显子第884位碱基由C变为A,导致蛋白质第295位的丝氨酸被酪氨酸取代(S295Y)。一名晚发型婴儿型MLD患者被发现该突变纯合。第二个突变是第7外显子第1144位核苷酸由G变为A,导致第382位氨基酸的谷氨酸被赖氨酸取代(E382K)。一名青少年型MLD患者被发现该突变纯合。最后,一名成年MLD患者被证明在第3外显子中有两个新的点突变杂合。这两个突变均为第635位和671位的C变为T,导致ASA蛋白第212位(A212V)和第224位(A224V)的丙氨酸被缬氨酸取代。